Literature DB >> 26189254

Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.

Q Ye, L Lei, A X Aili.   

Abstract

PURPOSE OF INVESTIGATION: To provide a systematic overview to understand the mechanism of ovarian cancer.
MATERIALS AND METHODS: Data of GSE14407 downloaded from Gene Expression Omnibus (GEO) database and differentially expressed genes (DEGs) were identified. Gene ontology and pathway enrichment analysis were performed by Database for Annotation, Visualization and Integrated Discovery (DAVID). Furthermore, the authors constructed the protein-protein interaction (PPI) network and co-expression networks by Cytoscape.
RESULTS: A total 1,442 genes were identified to be differentially expressed. Regulatory effects of DEGs mainly focused on cell cycle, transcription regulation, and cellular protein metabolic process. Significant pathways were determined to be p53 signaling pathway, amino sugar, and nucleotide sugar metabolism. The most significant transcription factor was aryl hydrocarbon receptor nuclear translocator (ARNT). Abnormal spindle-like microcephaly-associated protein (ASPM), Aurora kinase (AURKA), Cyclin-A2 (CCNA2), G2/mitotic-specific cyclin-B1, (CCNB1), and Cyclin-dependent kinase 1 (CDK1) were significant nodes in PPI network.
CONCLUSION: The significant genes and pathways show potential targets for the treatment of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26189254

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.

Authors:  Yiguo Wu; Yujuan You; Ling Chen; Yue Liu; Yujuan Liu; Weiming Lou; Fen Fu
Journal:  Gland Surg       Date:  2022-04

2.  Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines.

Authors:  Cong Wang; Qin Yan; Minmin Hu; Di Qin; Zhenqing Feng
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

3.  Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.

Authors:  Elizabeth A Mazzio; Charles A Lewis; Rashid Elhag; Karam F Soliman
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 3.395

4.  Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.

Authors:  Majid Momeny; Zahra Sabourinejad; Ghazaleh Zarrinrad; Farima Moghaddaskho; Haniyeh Eyvani; Hassan Yousefi; Shahab Mirshahvaladi; Ensieh M Poursani; Farinaz Barghi; Arash Poursheikhani; Leila Dardaei; Davood Bashash; Mahmoud Ghazi-Khansari; Seyyed M Tavangar; Ahmad R Dehpour; Marjan Yaghmaie; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Seyed H Ghaffari
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

5.  Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.

Authors:  Sha Lv; Xiaoxiao Xu; Zhangying Wu
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

6.  A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.

Authors:  Karuna Mittal; Da Hoon Choi; Sergey Klimov; Shrikant Pawar; Ramneet Kaur; Anirban K Mitra; Meenakshi V Gupta; Ralph Sams; Guilherme Cantuaria; Padmashree C G Rida; Ritu Aneja
Journal:  J Ovarian Res       Date:  2016-03-18       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.